ODO1_STAAU
ID ODO1_STAAU Reviewed; 932 AA.
AC P0C601; Q7ASB7; Q7WRM3; Q7WRN1; Q7WRX0; Q7WZ40;
DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT 15-JAN-2008, sequence version 1.
DT 25-MAY-2022, entry version 53.
DE RecName: Full=2-oxoglutarate dehydrogenase E1 component {ECO:0000255|HAMAP-Rule:MF_01169};
DE EC=1.2.4.2 {ECO:0000255|HAMAP-Rule:MF_01169};
DE AltName: Full=Alpha-ketoglutarate dehydrogenase {ECO:0000255|HAMAP-Rule:MF_01169};
GN Name=odhA {ECO:0000255|HAMAP-Rule:MF_01169};
OS Staphylococcus aureus.
OC Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC Staphylococcus.
OX NCBI_TaxID=1280;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=FranceDuf, Glasgow3700, Glasgow3759, LIM1, LIM2, LIM3, LiverpoolAG,
RC LLA, LLE, Michigan, New Jersey, Norway1018, PC1, PC3, Slovenia6096,
RC SMH10501, SMH11888, SMH12248, SMH14017, SMH17487, SMH17608, SMH18000,
RC SMH18034, SMH18037, SMH2, SMH8997, Southampton23, St. Luke, Sweden307, and
RC Sweden309;
RA Wootton M., Avison M.B., Bennett P.M., Howe R.A., MacGowan A.P.,
RA Walsh T.R.;
RT "Genetic analysis of seventeen genes in Staphylococcus aureus with reduced
RT susceptibility to vancomycin (VRSA) and hetero-VRSA (hVRSA).";
RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: E1 component of the 2-oxoglutarate dehydrogenase (OGDH)
CC complex which catalyzes the decarboxylation of 2-oxoglutarate, the
CC first step in the conversion of 2-oxoglutarate to succinyl-CoA and
CC CO(2). {ECO:0000255|HAMAP-Rule:MF_01169}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=(R)-N(6)-lipoyl-L-lysyl-[dihydrolipoyllysine-residue
CC succinyltransferase] + 2-oxoglutarate + H(+) = (R)-N(6)-(S(8)-
CC succinyldihydrolipoyl)-L-lysyl-[dihydrolipoyllysine-residue
CC succinyltransferase] + CO2; Xref=Rhea:RHEA:12188, Rhea:RHEA-
CC COMP:10483, Rhea:RHEA-COMP:10484, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:83099,
CC ChEBI:CHEBI:83120; EC=1.2.4.2; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_01169};
CC -!- COFACTOR:
CC Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_01169};
CC -!- SUBUNIT: Homodimer. Part of the 2-oxoglutarate dehydrogenase (OGDH)
CC complex composed of E1 (2-oxoglutarate dehydrogenase), E2
CC (dihydrolipoamide succinyltransferase) and E3 (dihydrolipoamide
CC dehydrogenase); the complex contains multiple copies of the three
CC enzymatic components (E1, E2 and E3). {ECO:0000255|HAMAP-
CC Rule:MF_01169}.
CC -!- SIMILARITY: Belongs to the alpha-ketoglutarate dehydrogenase family.
CC {ECO:0000255|HAMAP-Rule:MF_01169}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AJ564531; CAD92198.1; -; Genomic_DNA.
DR EMBL; AJ564532; CAD92199.1; -; Genomic_DNA.
DR EMBL; AJ564533; CAD92200.1; -; Genomic_DNA.
DR EMBL; AJ564534; CAD92201.1; -; Genomic_DNA.
DR EMBL; AJ564535; CAD92202.1; -; Genomic_DNA.
DR EMBL; AJ564536; CAD92203.1; -; Genomic_DNA.
DR EMBL; AJ564537; CAD92204.1; -; Genomic_DNA.
DR EMBL; AJ564538; CAD92205.1; -; Genomic_DNA.
DR EMBL; AJ564539; CAD92206.1; -; Genomic_DNA.
DR EMBL; AJ564540; CAD92207.1; -; Genomic_DNA.
DR EMBL; AJ564541; CAD92208.1; -; Genomic_DNA.
DR EMBL; AJ564542; CAD92209.1; -; Genomic_DNA.
DR EMBL; AJ564543; CAD92210.1; -; Genomic_DNA.
DR EMBL; AJ564544; CAD92211.1; -; Genomic_DNA.
DR EMBL; AJ564545; CAD92212.1; -; Genomic_DNA.
DR EMBL; AJ564546; CAD92213.1; -; Genomic_DNA.
DR EMBL; AJ564547; CAD92214.1; -; Genomic_DNA.
DR EMBL; AJ564548; CAD92215.1; -; Genomic_DNA.
DR EMBL; AJ564549; CAD92216.1; -; Genomic_DNA.
DR EMBL; AJ564550; CAD92217.1; -; Genomic_DNA.
DR EMBL; AJ564551; CAD92218.1; -; Genomic_DNA.
DR EMBL; AJ564552; CAD92219.1; -; Genomic_DNA.
DR EMBL; AJ564553; CAD92220.1; -; Genomic_DNA.
DR EMBL; AJ564554; CAD92221.1; -; Genomic_DNA.
DR EMBL; AJ564555; CAD92222.1; -; Genomic_DNA.
DR EMBL; AJ564556; CAD92223.1; -; Genomic_DNA.
DR EMBL; AJ564557; CAD92224.1; -; Genomic_DNA.
DR EMBL; AJ564558; CAD92225.1; -; Genomic_DNA.
DR EMBL; AJ564559; CAD92226.1; -; Genomic_DNA.
DR EMBL; AJ564560; CAD92227.1; -; Genomic_DNA.
DR EMBL; AJ564561; CAD92228.1; -; Genomic_DNA.
DR RefSeq; WP_000180650.1; NZ_CP026957.1.
DR RefSeq; WP_000180688.1; NZ_LSBF01000026.1.
DR AlphaFoldDB; P0C601; -.
DR SMR; P0C601; -.
DR GO; GO:0004591; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; IEA:UniProtKB-UniRule.
DR GO; GO:0030976; F:thiamine pyrophosphate binding; IEA:UniProtKB-UniRule.
DR GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-UniRule.
DR GO; GO:0006099; P:tricarboxylic acid cycle; IEA:InterPro.
DR Gene3D; 3.40.50.11610; -; 1.
DR HAMAP; MF_01169; SucA_OdhA; 1.
DR InterPro; IPR011603; 2oxoglutarate_DH_E1.
DR InterPro; IPR023784; 2oxoglutarate_DH_E1_bac.
DR InterPro; IPR001017; DH_E1.
DR InterPro; IPR031717; KGD_C.
DR InterPro; IPR042179; KGD_C_sf.
DR InterPro; IPR029061; THDP-binding.
DR InterPro; IPR005475; Transketolase-like_Pyr-bd.
DR PANTHER; PTHR23152; PTHR23152; 1.
DR Pfam; PF00676; E1_dh; 1.
DR Pfam; PF16870; OxoGdeHyase_C; 1.
DR Pfam; PF02779; Transket_pyr; 1.
DR PIRSF; PIRSF000157; Oxoglu_dh_E1; 1.
DR SMART; SM00861; Transket_pyr; 1.
DR SUPFAM; SSF52518; SSF52518; 2.
DR TIGRFAMs; TIGR00239; 2oxo_dh_E1; 1.
PE 3: Inferred from homology;
KW Glycolysis; Oxidoreductase; Thiamine pyrophosphate.
FT CHAIN 1..932
FT /note="2-oxoglutarate dehydrogenase E1 component"
FT /id="PRO_0000224241"
FT VARIANT 46..67
FT /note="Missing (in strain: SMH8997, LLA, LLE, SMH10501,
FT SMH11888, SMH12248, SMH14017, SMH17487, SMH17608, SMH18000,
FT SMH18034 and SMH18037)"
FT VARIANT 534
FT /note="E -> D (in strain: 23, 3700, 3759, LIM1, LIM2 and
FT LIM3)"
FT VARIANT 864
FT /note="K -> N (in strain: 23, 3700, 3759, LIM1, LIM2 and
FT LIM3)"
SQ SEQUENCE 932 AA; 105383 MW; C744C1868AE20A38 CRC64;
MTNERKEVSE APVNFGANLG LMLDLYDDFL QDPSSVPEDL QVLFSIIKND DSIVPALKST
SSQNSDGTIK RVMRLIDNIR QYGHLKADIY PVNPPKRKHV PKLEIEDFDL DQQTLEGISA
GIVSDHFADI YDNAYEAILR MEKRYKGPIA FEYTHINNNT ERGWLKRRIE TPYKVTLNNN
EKRALFKQLA YVEGFEKYLH KNFVGAKRFS IEGVDALVPM LQRTITIAAK EGIKNIQIGM
AHRGRLNVLT HVLEKPYEMM ISEFMHTDPM KFLPEDGSLQ LTAGWTGDVK YHLGGIKTTD
SYGTMQRIAL ANNPSHLEIV APVVEGRTRA AQDDTQRAGA PTTDHHKAMP IIIHGDAAYP
GQGINFETMN LGNLKGYSTG GSLHIITNNR IGFTTEPIDA RSTTYSTDVA KGYDVPIFHV
NADDVEATIE AIDIAMEFRK EFHKDVVIDL VGYRRFGHNE MDEPSITNPV PYQNIRKHDS
VEYVFGKKLV NEGVISEDEM HSFIEQVQKE LRQAHDKINK ADKMDNPDME KPAELALPLQ
ADEQSFTFDH LKEINDALLT YPDGFNILKK LNKVLEKRHE PFNKEDGLVD WAQAEQLAFA
TILQDGTPIR LTGQDSERGT FSHRHAVLHD EQTGETYTPL HHVPDQKATF DIHNSPLSEA
AVVGFEYGYN VENKKSFNIW EAQYGDFANM SQMIFDNFLF SSRSKWGERS GLTLFLPHAY
EGQGPEHSSA RLERFLQLAA ENNCTVVNLS SSSNYFHLLR AQAASLDSEQ MRPLVVMSPK
SLLRNKTVAK PIDEFTSGGF EPILTESYQA DKVTKVILAT GKMFIDLKEA LAKNPDESVL
LVAIERLYPF PEEEIEALLA QLPKLEEVSW VQEEPKNQGA WLYVYPYVKV LVADKYDLSY
HGRIQRAAPA EGDGEIHKLV QNKIIENALK NN
